Anika Therapeutics reported $167.86M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Agenus AGEN:US $ 288.93M 1.55M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Chemocentryx CCXI:US $ 345.17M 6.46M
Clovis Oncology CLVS:US $ 142.28M 43.25M
Enanta Pharmaceuticals ENTA:US $ 313.04M 28.83M
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Immunogen IMGN:US $ 373.87M 82.84M
Insmed INSM:US $ 674.73M 81.41M
Integra Lifesciences IART:US $ 1.14B 71.36M
Intrexon XON:US $ 164.62M 9.68M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Macrogenics MGNX:US $ 167.63M 50.57M
Merit Medical Systems MMSI:US $ 492.63M 14.54M
Peregrine Pharmaceuticals PPHM:US $ 180.02M 23.47M
Rigel Pharmaceuticals RIGL:US $ 120.52M 18.42M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Stryker SYK:US $ 8825M 100M
Surmodics SRDX:US $ 60.04M 4.65M
Veracyte VCYT:US $ 235.04M 3.44M
Xencor XNCR:US $ 585.94M 79.97M
Zimmer Biomet Holdings Inc ZBH:US $ 4.46B 53.9M